Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report

Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.

Detalles Bibliográficos
Autores principales: Beziat, Guillaume, Gauthier, Martin, Protin, Caroline, Oberic, Lucie, Lerebours, Fleur, Carlier, Jasmine, Ysebaert, Loïc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044374/
https://www.ncbi.nlm.nih.gov/pubmed/32128171
http://dx.doi.org/10.1002/ccr3.2580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044374/
https://www.ncbi.nlm.nih.gov/pubmed/32128171
http://dx.doi.org/10.1002/ccr3.2580

Ejemplares similares